Our sectors

We treat all personal data in accordance with our privacy policy.

Textured Breast Implant Claims

In December 2018, Allergan textured breast implants were removed from the market in Europe due to them being linked to a rare form of cancer called Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL).

Reported symptoms tend to describe a late onset of painful swollen breasts with a fluid collection usually between three and 14 years after implantation. Although investigations into the pathology of BIA-ALCL continue, positive outcomes have been reported and in most cases patients have achieved complete remission.

Leigh Day is currently investigating claims on behalf of women who have had a diagnosis of BIA-ALCL or are being investigated for BIA-ALCL. If you would like to speak to a member of our team regarding a potential BIA-ALCL claim, please email us.

If you have not had a diagnosis of BIA-ALCL but are concerned about developing this condition, and would like to be added to our mailing list so that we can keep you up to date on what we are doing at Leigh Day in regards to BIA-ALCL, register your interest and we can inform you if we are able to pursue legal action for you in the future.  
Register your interest

Julie's story

Julie Harris had the Allergan textured breast implants in 2011.

In 2018, she was diagnosed with Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

Watch her story below.

Read our blogs

Solicitor Zahra Nanji, who represents 20 women who have the breast implant related cancer BIA-ALCL, discusses recent developments in the US following the worldwide voluntary recall of Allergan textured implants last month.

Lawyers for women with BIA-ALCL welcome Allergan worldwide voluntary recall
Lawyers acting on behalf of 13 women who have the breast implant related cancer BIA-ALCL have welcomed the announcement from the U.S. Food and Drug Administration (FDA) that it had requested that Allergan recall specific models of its textured breast implants from the U.S. market.

Early diagnosis is key in the rare cancer linked to textured breast implants
Solicitor Zahra Nanji is currently investigating a legal claim for over 350 women who have Allergan textured breast implants which have been linked to a rare form of cancer known as BIA-ALCL

Dispatches breast implant scandal investigation – what was missing from the MHRA response?
Channel 4’s Dispatches documentary series last night explored ‘Britain’s Breast Implant Scandal’. One of the issues raised in the show was the link between textured breast implants and a rare form of cancer known as BIA-ALCL. 

Health Canada suspends licences for Allergan’s Biocell breast implants
Solicitor Zahra Nanji discusses the recent announcement by Health Canada to suspend licences for Allergan’s Biocell breast implants, due to concerns about links to a rare form of cancer, and whether this should lead to stronger action from the UK health regulator.

Share this page: Print this page